BARI GENOA: Open Payments
NPI 1902466170 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74,970 in 198 payments from 16 companies in 2025. Trend: 2023 $55,235 · 2024 $62,902 · 2025 $74,970
Speaker / faculty: $60,822Travel & lodging: $6,525Food & beverage: $4,668Consulting: $2,890Education: $65
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 67 | $42,538 |
| Lilly USA, LLC | 42 | $25,051 |
| E.R. Squibb & Sons, L.L.C. | 11 | $2,164 |
| GENZYME CORPORATION | 5 | $1,989 |
| Arcutis Biotherapeutics, Inc. | 4 | $1,456 |
| ABBVIE INC. | 21 | $367 |
| Organon LLC | 4 | $259 |
| LEO Pharma Inc. | 4 | $241 |
| Janssen Biotech, Inc. | 9 | $228 |
| Novartis Pharmaceuticals Corporation | 8 | $183 |
Products named: Bimzelx, EBGLYSS, DUPIXENT, Zoryve, Sotyktu, ANZUPGO, VTAMA, TREMFYA.
Industry payments across NY — which companies pay providers there.
